Detail akcie LeMaitre online

Business Summary: LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, LeMaitre Vascular Inc revenues increased 14% to $249.6M. Net income increased 31% to $57.7M. Revenues reflect United States segment increase of 10% to $141.6M, Other countries segment increase of 18% to $61.7M, Germany segment increase of 24% to $17.9M. Net income benefited from anastomotic clips, angioscopes, biologic vascular and dialys segment income increase of 30% to $67.9M.